{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T14:54:35Z","timestamp":1782226475357,"version":"3.54.5"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","award":["ZYJC21007"],"award-info":[{"award-number":["ZYJC21007"]}],"id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","award":["2024HXBH090"],"award-info":[{"award-number":["2024HXBH090"]}],"id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2024NSFSC1697"],"award-info":[{"award-number":["2024NSFSC1697"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82,470,196"],"award-info":[{"award-number":["82,470,196"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070219"],"award-info":[{"award-number":["82070219"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018525","name":"Key Research and Development Program of Sichuan Province","doi-asserted-by":"publisher","award":["2023YFS0031"],"award-info":[{"award-number":["2023YFS0031"]}],"id":[{"id":"10.13039\/501100018525","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013365","name":"West China Hospital, Sichuan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["82370192"],"award-info":[{"award-number":["82370192"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2502600"],"award-info":[{"award-number":["2022YFC2502600"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2502603"],"award-info":[{"award-number":["2022YFC2502603"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.bcp.2025.116855","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T11:10:11Z","timestamp":1741173011000},"page":"116855","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["The mitochondrial protease ClpP is a promising target for multiple myeloma treatment"],"prefix":"10.1016","volume":"236","author":[{"given":"Xiang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlong","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingcao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyue","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianwen","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haonan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youfu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bcp.2025.116855_b0005","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.bcp.2025.116855_b0010","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-024-00529-7","article-title":"Multiple myeloma","volume":"10","author":"Malard","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"1","key":"10.1016\/j.bcp.2025.116855_b0015","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s40164-024-00525-3","article-title":"Advances in nano-immunotherapy for hematological malignancies","volume":"13","author":"Xu","year":"2024","journal-title":"Exp. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.bcp.2025.116855_b0020","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s13045-020-01001-1","article-title":"Safety and clinical efficacy of BCMA CAR-T-cell therapy in multiple myeloma","volume":"13","author":"Roex","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"14","key":"10.1016\/j.bcp.2025.116855_b0025","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1200\/JCO.18.02096","article-title":"Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline","volume":"37","author":"Mikhael","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bcp.2025.116855_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40364-021-00344-2","article-title":"The changing landscape of relapsed and\/or refractory multiple myeloma (MM): fundamentals and controversies","volume":"10","author":"Hern\u00e1ndez-Rivas","year":"2022","journal-title":"Biomark Res"},{"issue":"67","key":"10.1016\/j.bcp.2025.116855_b0035","doi-asserted-by":"crossref","first-page":"111213","DOI":"10.18632\/oncotarget.22740","article-title":"Alteration of mitochondrial biogenesis promotes disease progression in multiple myeloma","volume":"8","author":"Zhan","year":"2017","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.bcp.2025.116855_b0040","doi-asserted-by":"crossref","first-page":"e415","DOI":"10.3324\/haematol.2018.207704","article-title":"A metabolic switch in proteasome inhibitor-resistant multiple myeloma ensures higher mitochondrial metabolism, protein folding and sphingomyelin synthesis","volume":"104","author":"Besse","year":"2019","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.bcp.2025.116855_b0045","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1038\/leu.2016.102","article-title":"Proteasome inhibitor-adapted myeloma cells are largely independent from proteasome activity and show complex proteomic changes, in particular in redox and energy metabolism","volume":"30","author":"Soriano","year":"2016","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.bcp.2025.116855_b0050","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13045-022-01269-5","article-title":"A novel role of lysophosphatidic acid (LPA) in human myeloma resistance to proteasome inhibitors","volume":"15","author":"Su","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"10","key":"10.1016\/j.bcp.2025.116855_b0055","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/s41419-020-03062-z","article-title":"Mitochondrial ClpP serine protease-biological function and emerging target for cancer therapy","volume":"11","author":"Nouri","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2025.116855_b0060","doi-asserted-by":"crossref","first-page":"18375","DOI":"10.1038\/srep18375","article-title":"Identification of potential mitochondrial CLPXP protease interactors and substrates suggests its central role in energy metabolism","volume":"5","author":"Fischer","year":"2015","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.bcp.2025.116855_b0065","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.ccell.2015.05.004","article-title":"Inhibition of the Mitochondrial Protease ClpP as a Therapeutic Strategy for Human Acute Myeloid Leukemia","volume":"27","author":"Cole","year":"2015","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.bcp.2025.116855_b0070","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1021\/acschembio.9b00347","article-title":"Chemical Modulation of Human Mitochondrial ClpP: Potential Application in Cancer Therapeutics","volume":"14","author":"Wong","year":"2019","journal-title":"ACS Chem. Biol."},{"issue":"13","key":"10.1016\/j.bcp.2025.116855_b0075","doi-asserted-by":"crossref","first-page":"10622","DOI":"10.1021\/acs.jmedchem.4c00080","article-title":"Discovery of 5-(Piperidin-4-yl)-1,2,4-oxadiazole Derivatives as a New Class of Human Caseinolytic Protease P Agonists for the Treatment of Hepatocellular Carcinoma","volume":"67","author":"Liu","year":"2024","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.bcp.2025.116855_b0080","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1038\/nprot.2007.321","article-title":"The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability","volume":"2","author":"Niesen","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bcp.2025.116855_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2021.338561","article-title":"A hybrid aggregate FRET probe from the mixed assembly of cyanine dyes for highly specific monitoring of mitochondria autophagy","volume":"1165","author":"Guo","year":"2021","journal-title":"Anal. Chim. Acta"},{"issue":"12","key":"10.1016\/j.bcp.2025.116855_b0090","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol."},{"issue":"5","key":"10.1016\/j.bcp.2025.116855_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2019.03.014","article-title":"Mitochondrial ClpP-Mediated Proteolysis Induces Selective Cancer Cell Lethality","volume":"35","author":"Ishizawa","year":"2019","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.bcp.2025.116855_b0100","doi-asserted-by":"crossref","first-page":"6769","DOI":"10.1021\/acs.jmedchem.4c00338","article-title":"Rational Design of a Novel Class of Human ClpP Agonists through a Ring-Opening Strategy with Enhanced Antileukemia Activity","volume":"67","author":"Xiang","year":"2024","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.bcp.2025.116855_b0105","article-title":"Aberrant human ClpP activation disturbs mitochondrial proteome homeostasis to suppress pancreatic ductal adenocarcinoma. Cell","volume":"29","author":"Wang","year":"2022","journal-title":"Chem. Biol."},{"issue":"2","key":"10.1016\/j.bcp.2025.116855_b0110","doi-asserted-by":"crossref","DOI":"10.1038\/s41580-019-0173-8","article-title":"Mitochondria as multifaceted regulators of cell death","volume":"21","author":"Bock","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.bcp.2025.116855_b0115","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s40164-022-00304-y","article-title":"Impaired mitochondria of Tregs decreases OXPHOS-derived ATP in primary immune thrombocytopenia with positive plasma pathogens detected by metagenomic sequencing","volume":"11","author":"Zhan","year":"2022","journal-title":"Exp. Hematol. Oncol."},{"issue":"4","key":"10.1016\/j.bcp.2025.116855_b0120","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15041112","article-title":"Autophagy\/Mitophagy Regulated by Ubiquitination: A Promising Pathway in Cancer Therapeutics","volume":"15","author":"Jee","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.bcp.2025.116855_b0125","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jhep.2018.09.022","article-title":"Ketoconazole exacerbates mitophagy to induce apoptosis by downregulating cyclooxygenase-2 in hepatocellular carcinoma","volume":"70","author":"Chen","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bcp.2025.116855_b0130","doi-asserted-by":"crossref","unstructured":"Klionsky DJ, Abdelmohsen K, Abe A, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy 2016;12(1) doi: 10.1080\/15548627.2015.1100356.","DOI":"10.1080\/15548627.2015.1100356"},{"key":"10.1016\/j.bcp.2025.116855_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceb.2015.01.002","article-title":"PINK1\/Parkin-mediated mitophagy in mammalian cells","volume":"33","author":"Eiyama","year":"2015","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.bcp.2025.116855_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2024.110110","article-title":"PINK1 insufficiency can be exploited as a specific target for drug combinations inducing mitochondrial pathology-mediated cell death in gastric adenocarcinoma","volume":"759","author":"Ghosh","year":"2024","journal-title":"Arch. Biochem. Biophys."},{"issue":"2","key":"10.1016\/j.bcp.2025.116855_b0145","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/bjh.19468","article-title":"Decreased RNA-binding protein heterogeneous nuclear ribonucleoprotein U improves multiple myeloma sensitivity to lenalidomide","volume":"205","author":"Lin","year":"2024","journal-title":"Br. J. Haematol."},{"issue":"Supplement 1","key":"10.1016\/j.bcp.2025.116855_b0150","doi-asserted-by":"crossref","first-page":"7072","DOI":"10.1182\/blood-2022-164536","article-title":"Targeting the Mitochondrial Protease Clpp Unveils Mitochondrial Vulnerabilities in Multiple Myeloma","volume":"140","author":"Perini","year":"2022","journal-title":"Blood"},{"issue":"Supplement 1","key":"10.1016\/j.bcp.2025.116855_b0155","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1182\/blood-2023-190766","article-title":"Caseinolytic Mitochondrial Matrix Peptidase Proteolytic Subunit (CLPP) As a Novel Mediator of, and Target in High Risk Multiple Myeloma","volume":"142","author":"Qin","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2025.116855_b0160","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.604143","article-title":"Mitochondrial Bioenergetics at the Onset of Drug Resistance in Hematological Malignancies: An Overview","volume":"10","author":"Barbato","year":"2020","journal-title":"Front. Oncol."},{"issue":"12","key":"10.1016\/j.bcp.2025.116855_b0165","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41580-022-00506-6","article-title":"Mechanisms of mitochondrial respiratory adaptation","volume":"23","author":"Bennett","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.bcp.2025.116855_b0170","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1007\/s12013-024-01366-x","article-title":"A Comprehensive Pan-Cancer Analysis of Cytochrome C Oxidase Assembly Factor 1 (COA1) Reveals Instrumental Role of Mitochondrial Protein Assembly in Cancer that Modulates Disease Progression and Prognostic Outcome","volume":"82","author":"Ghosh","year":"2024","journal-title":"Cell Biochem. Biophys."},{"issue":"9","key":"10.1016\/j.bcp.2025.116855_b0175","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1158\/0008-5472.CAN-18-0773","article-title":"CD38-Driven Mitochondrial Trafficking Promotes Bioenergetic Plasticity in Multiple Myeloma","volume":"79","author":"Marlein","year":"2019","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.bcp.2025.116855_b0180","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1038\/bjc.2013.120","article-title":"Dichloroacetate inhibits aerobic glycolysis in multiple myeloma cells and increases sensitivity to bortezomib","volume":"108","author":"Sanchez","year":"2013","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2025.116855_b0185","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/bjc.2012.527","article-title":"PDK1 inhibition is a novel therapeutic target in multiple myeloma","volume":"108","author":"Fujiwara","year":"2013","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2025.116855_b0190","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/s41467-020-15051-z","article-title":"Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myeloma","volume":"11","author":"Bajpai","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2025.116855_b0195","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40164-022-00283-0","article-title":"Progress in understanding the mechanisms of resistance to BCL-2 inhibitors","volume":"11","author":"Xu","year":"2022","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.bcp.2025.116855_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117971","article-title":"SR18292 exerts potent antitumor effects in multiple myeloma via inhibition of oxidative phosphorylation","volume":"256","author":"Xiang","year":"2020","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.bcp.2025.116855_b0205","doi-asserted-by":"crossref","first-page":"7069","DOI":"10.1038\/s41467-023-42784-4","article-title":"Selective activator of human ClpP triggers cell cycle arrest to inhibit lung squamous cell carcinoma","volume":"14","author":"Zhou","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2025.116855_b0210","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1474-9726.2009.00538.x","article-title":"Low complex I content explains the low hydrogen peroxide production rate of heart mitochondria from the long-lived pigeon","volume":"9","author":"Lambert","year":"2010","journal-title":"Columba Livia. Aging Cell"},{"issue":"3","key":"10.1016\/j.bcp.2025.116855_b0215","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.bbrc.2016.10.088","article-title":"Mitophagy: Link to cancer development and therapy","volume":"482","author":"Kulikov","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2025.116855_b0220","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.semcancer.2019.07.015","article-title":"The emerging, multifaceted role of mitophagy in cancer and cancer therapeutics","volume":"66","author":"Panigrahi","year":"2020","journal-title":"Semin. Cancer Biol."},{"issue":"8","key":"10.1016\/j.bcp.2025.116855_b0225","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1007\/s00018-021-03774-1","article-title":"Mitophagy in tumorigenesis and metastasis","volume":"78","author":"Poole","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bcp.2025.116855_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216802","article-title":"Targeting PARP14 with lomitapide suppresses drug resistance through the activation of DRP1-induced mitophagy in multiple myeloma","volume":"588","author":"Zhang","year":"2024","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.bcp.2025.116855_b0235","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s13045-020-00993-0","article-title":"Blocking of Transient Receptor Potential Vanilloid 1 (TRPV1) promotes terminal mitophagy in multiple myeloma, disturbing calcium homeostasis and targeting ubiquitin pathway and bortezomib-induced unfolded protein response","volume":"13","author":"Beider","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"4","key":"10.1016\/j.bcp.2025.116855_b0240","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1080\/15384101.2017.1403689","article-title":"Single agent and synergistic combinatorial efficacy of first-in-class small molecule imipridone ONC201 in hematological malignancies","volume":"17","author":"Prabhu","year":"2018","journal-title":"Cell Cycle"},{"issue":"10","key":"10.1016\/j.bcp.2025.116855_b0245","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.neo.2017.07.009","article-title":"The Imipridone ONC201 Induces Apoptosis and Overcomes Chemotherapy Resistance by Up-Regulation of Bim in Multiple Myeloma","volume":"19","author":"Tu","year":"2017","journal-title":"Neoplasia"},{"issue":"12","key":"10.1016\/j.bcp.2025.116855_b0250","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.neo.2020.09.005","article-title":"ONC201 and imipridones: Anti-cancer compounds with clinical efficacy","volume":"22","author":"Prabhu","year":"2020","journal-title":"Neoplasia"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225001170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225001170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:59:51Z","timestamp":1777377591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225001170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":50,"alternative-id":["S0006295225001170"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.116855","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The mitochondrial protease ClpP is a promising target for multiple myeloma treatment","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.116855","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116855"}}